Rodrigo Canada Surjan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Rodrigo Canada Surjan has a total of 153 co-authors. Here are the top co-authors by number of shared publications:
- Marcel Autran Cesar Machado
Hospital Nove de Julho, Sao Paulo, Brazil
37 shared publications Fabio F. Makdissi
Department of Gastroenterology, University of São Paulo, São Paulo, SP, Brazil
18 shared publicationsTiago Basseres
Nove de Julho Hospital, São Paulo, Brazil
14 shared publicationsFábio F. Makdissi
University of Sao Paulo, Sao Paulo, Brazil
7 shared publicationsFábio Ferrari Makdissi
Sírio Libanês Hospital , São Paulo, Brazil
7 shared publicationsMarcel Autran Cesar Machado
Department of Surgery, University of São Paulo Medical School, São Paulo, Brazil
7 shared publications
Latest Publications
- Open Access
- 27 May 2026
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 46 (02) , 001-006
Rectal Sensory Testing in Anorectal Disorders: A Critical Review of Neurophysiological and Biomechanical Perspectives
Rectal sensory dysfunction plays a central role in constipation, fecal incontinence, and functional defecatory disorders, yet its physiological basis and clinical interpretation remain not completely established. Advances in neuroanatomy and high-resolution anorectal manometry (HRAM) have reshaped current diagnostic paradigms, prompting reconsideration of the traditional threshold-based definition of rectal hyposensitivity. To provide the current mechanisms of rectal sensitivity measurements with critical analysis, and to show the emerging technological advances that can fill the existing gaps as well as the possibilities in the future. The present narrative review synthesizes emerging evidence on anorectal neurophysiology, HRAM-derived sensory thresholds, biomechanical contributors to rectal perception, and the role of novel technologies, such as translumbosacral magnetic stimulation and endoluminal functional lumen imaging probe (EndoFLIP) (technologies scheduled to arrive in Brazil this year), and the interaction of artificial intelligence (AI). Multicenter HRAM datasets evaluating the clinical significance of isolated abnormal thresholds were critically examined. Rectal sensory thresholds reflect a complex interplay of afferent signaling, rectal wall biomechanics, and cortical processing. Multicenter analyses show that even a single elevated threshold may correlate with symptom severity, especially in women, although using a one-threshold definition. Distinguishing primary afferent dysfunction from biomechanical alterations is crucial, with pressure-volume analysis and emerging technologies offering complementary insights. Sensory biofeedback improves outcomes in true afferent hyposensitivity but is less effective when biomechanical factors predominate. Current evidence supports maintaining the London Classification definition of rectal hyposensitivity (≥ 2 abnormal thresholds), while recognizing that isolated abnormalities may indicate early dysfunction in selected patients. Integrating HRAM findings with biomechanical and neurophysiological metrics may refine diagnostic precision. Future developments may allow a single abnormal parameter to reliably define clinically meaningful rectal hyposensitivity.
- 27 May 2026
- Published by Georg Thieme Verlag KG in Journal of Coloproctology
- Vol. 46 (02) , 001-006
Open AccessRectal Sensory Testing in Anorectal Disorders: A Critical Review of Neurophysiological and Biomechanical Perspectives
Rectal sensory dysfunction plays a central role in constipation, fecal incontinence, and functional defecatory disorders, yet its physiological basis and clinical interpretation remain not completely established. Advances in neuroanatomy and high-resolution anorectal manometry (HRAM) have reshaped current diagnostic paradigms, prompting reconsideration of the traditional threshold-based definition of rectal hyposensitivity. To provide the current mechanisms of rectal sensitivity measurements with critical analysis, and to show the emerging technological advances that can fill the existing gaps as well as the possibilities in the future. The present narrative review synthesizes emerging evidence on anorectal neurophysiology, HRAM-derived sensory thresholds, biomechanical contributors to rectal perception, and the role of novel technologies, such as translumbosacral magnetic stimulation and endoluminal functional lumen imaging probe (EndoFLIP) (technologies scheduled to arrive in Brazil this year), and the interaction of artificial intelligence (AI). Multicenter HRAM datasets evaluating the clinical significance of isolated abnormal thresholds were critically examined. Rectal sensory thresholds reflect a complex interplay of afferent signaling, rectal wall biomechanics, and cortical processing. Multicenter analyses show that even a single elevated threshold may correlate with symptom severity, especially in women, although using a one-threshold definition. Distinguishing primary afferent dysfunction from biomechanical alterations is crucial, with pressure-volume analysis and emerging technologies offering complementary insights. Sensory biofeedback improves outcomes in true afferent hyposensitivity but is less effective when biomechanical factors predominate. Current evidence supports maintaining the London Classification definition of rectal hyposensitivity (≥ 2 abnormal thresholds), while recognizing that isolated abnormalities may indicate early dysfunction in selected patients. Integrating HRAM findings with biomechanical and neurophysiological metrics may refine diagnostic precision. Future developments may allow a single abnormal parameter to reliably define clinically meaningful rectal hyposensitivity.
- Open Access
- 27 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e81295
Idiopathic Myointimal Hyperplasia of the Mesenteric Veins: A Rare Mimic of Inflammatory Bowel Disease
Idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) is a rare cause of segmental intestinal ischemia. It is usually associated with chronic symptoms of abdominal pain, diarrhea, and rectal bleeding, but it also can present in more acute and dramatic clinical presentations. Surgical segmental bowel resection is the proper treatment, but it is commonly delayed by the misdiagnosis of this condition as inflammatory bowel disease, such as Crohn's or idiopathic ulcerative colitis. Awareness of IMHMV as a non-thrombotic cause of intestinal ischemia may prevent unnecessary medical treatment with topical and systemic steroids, antibiotics, and even mesalazine and avoid potentially fatal complications of the disease. We report a case with early development of severe complications and also review the literature on IMHMV.
- 27 March 2025
- Published by Springer Nature in Cureus
- Vol. 17 (3) , e81295
Open AccessIdiopathic Myointimal Hyperplasia of the Mesenteric Veins: A Rare Mimic of Inflammatory Bowel Disease
Idiopathic myointimal hyperplasia of the mesenteric veins (IMHMV) is a rare cause of segmental intestinal ischemia. It is usually associated with chronic symptoms of abdominal pain, diarrhea, and rectal bleeding, but it also can present in more acute and dramatic clinical presentations. Surgical segmental bowel resection is the proper treatment, but it is commonly delayed by the misdiagnosis of this condition as inflammatory bowel disease, such as Crohn's or idiopathic ulcerative colitis. Awareness of IMHMV as a non-thrombotic cause of intestinal ischemia may prevent unnecessary medical treatment with topical and systemic steroids, antibiotics, and even mesalazine and avoid potentially fatal complications of the disease. We report a case with early development of severe complications and also review the literature on IMHMV.
- Open Access
- 1 January 2024
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 37, e1840
ROBOTIC PANCREATICODUODENECTOMY FOR THE TREATMENT OF A MIXED NEUROENDOCRINE-NON-NEUROENDOCRINE NEOPLASM (MINEN) OF THE AMPULLA OF VATER
Mixed neuroendocrine-non-neuroendocrine tumors (MiNEN) are a rare type of tumor formed by two components, a non-neuroendocrine component that is most often an adenocarcinoma and a neuroendocrine tumor, and each of these components must represent at least 30% of the tumor. The origin of this tumor on the ampulla of Vater or periampullary region is more infrequent. Usually, the lesions are highly aggressive and quickly metastasizing, and their biological behavior is dictated by the high grade of the neuroendocrine component. This is the first report of a patient with ampullary MiNEN treated employing a robotic pancreaticoduodenectomy. Although being submitted to aggressive treatment with complete surgical resection followed by systemic therapy, the patient developed early recurrence with hepatic metastatic disease, demonstrating the hostile nature of these tumors.
- 1 January 2024
- Published by FapUNIFESP (SciELO) in ABCD. Arquivos Brasileiros de Cirurgia Digestiva (São Paulo)
- Vol. 37, e1840
Open AccessROBOTIC PANCREATICODUODENECTOMY FOR THE TREATMENT OF A MIXED NEUROENDOCRINE-NON-NEUROENDOCRINE NEOPLASM (MINEN) OF THE AMPULLA OF VATER
Mixed neuroendocrine-non-neuroendocrine tumors (MiNEN) are a rare type of tumor formed by two components, a non-neuroendocrine component that is most often an adenocarcinoma and a neuroendocrine tumor, and each of these components must represent at least 30% of the tumor. The origin of this tumor on the ampulla of Vater or periampullary region is more infrequent. Usually, the lesions are highly aggressive and quickly metastasizing, and their biological behavior is dictated by the high grade of the neuroendocrine component. This is the first report of a patient with ampullary MiNEN treated employing a robotic pancreaticoduodenectomy. Although being submitted to aggressive treatment with complete surgical resection followed by systemic therapy, the patient developed early recurrence with hepatic metastatic disease, demonstrating the hostile nature of these tumors.
- Open Access
- 1 July 2023
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 9, 38
First description of extended and tailored fluorescence-guided lymphadenectomy during robotic distal pancreatosplenectomy: case report
Video 1 Fluorescence-guided lymphadenectomy: robotic distal pancreatosplenectomy. Authors: Rodrigo Cañada Trofo Surjan, Sergio do Prado Silveira, Estela Regina Ramos Figueira, Jose Celso Ardengh
- 1 July 2023
- Published by AME Publishing Company in Journal of Visualized Surgery
- Vol. 9, 38
Open AccessFirst description of extended and tailored fluorescence-guided lymphadenectomy during robotic distal pancreatosplenectomy: case report
Video 1 Fluorescence-guided lymphadenectomy: robotic distal pancreatosplenectomy. Authors: Rodrigo Cañada Trofo Surjan, Sergio do Prado Silveira, Estela Regina Ramos Figueira, Jose Celso Ardengh
- Open Access
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (25) , eadg7038
Disruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma
Fibrolamellar hepatocellular carcinoma (FLC) is a usually lethal primary liver cancer driven by a somatic dysregulation of protein kinase A. We show that the proteome of FLC tumors is distinct from that of adjacent nontransformed tissue. These changes can account for some of the cell biological and pathological alterations in FLC cells, including their drug sensitivity and glycolysis. Hyperammonemic encephalopathy is a recurrent problem in these patients, and established treatments based on the assumption of liver failure are unsuccessful. We show that many of the enzymes that produce ammonia are increased and those that consume ammonia are decreased. We also demonstrate that the metabolites of these enzymes change as expected. Thus, hyperammonemic encephalopathy in FLC may require alternative therapeutics.
- 23 June 2023
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 9 (25) , eadg7038
Open AccessDisruption of proteome by an oncogenic fusion kinase alters metabolism in fibrolamellar hepatocellular carcinoma
Fibrolamellar hepatocellular carcinoma (FLC) is a usually lethal primary liver cancer driven by a somatic dysregulation of protein kinase A. We show that the proteome of FLC tumors is distinct from that of adjacent nontransformed tissue. These changes can account for some of the cell biological and pathological alterations in FLC cells, including their drug sensitivity and glycolysis. Hyperammonemic encephalopathy is a recurrent problem in these patients, and established treatments based on the assumption of liver failure are unsuccessful. We show that many of the enzymes that produce ammonia are increased and those that consume ammonia are decreased. We also demonstrate that the metabolites of these enzymes change as expected. Thus, hyperammonemic encephalopathy in FLC may require alternative therapeutics.
- Open Access
- 17 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33861
First Robotic Roux-en-Y Gastric Bypass for the Treatment of Refractory Gastroesophageal Reflux Disease in a Patient With Systemic Sclerosis
Systemic sclerosis (SSc) is an immune-mediated disease that results in fibrosis of the skin and internal organs. Refractory gastroesophageal reflux disease (GERD) associated with severe esophageal dysmotility is common in SSc patients, and surgical treatment with usual anti-reflux procedures such as fundoplications is associated with dismal symptomatic relief and postoperative dysphagia. We report the first robotic short-limb Roux-en-Y gastric bypass (RYGB) with a short Roux limb for the treatment of GERD in a patient with SSc with intense esophageal dysmotility. The operative time was two hours. The procedure and postoperative course were uneventful. The patient presented complete relief of gastroesophageal reflux symptoms and no postoperative dysphagia in a two-year follow-up. Therefore, short-limb RYGB is a safe and very effective alternative for the treatment of severe GERD in patients with SSc. The robotic surgical platform may have some advantages compared to conventional laparoscopy.
- 17 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33861
Open AccessFirst Robotic Roux-en-Y Gastric Bypass for the Treatment of Refractory Gastroesophageal Reflux Disease in a Patient With Systemic Sclerosis
Systemic sclerosis (SSc) is an immune-mediated disease that results in fibrosis of the skin and internal organs. Refractory gastroesophageal reflux disease (GERD) associated with severe esophageal dysmotility is common in SSc patients, and surgical treatment with usual anti-reflux procedures such as fundoplications is associated with dismal symptomatic relief and postoperative dysphagia. We report the first robotic short-limb Roux-en-Y gastric bypass (RYGB) with a short Roux limb for the treatment of GERD in a patient with SSc with intense esophageal dysmotility. The operative time was two hours. The procedure and postoperative course were uneventful. The patient presented complete relief of gastroesophageal reflux symptoms and no postoperative dysphagia in a two-year follow-up. Therefore, short-limb RYGB is a safe and very effective alternative for the treatment of severe GERD in patients with SSc. The robotic surgical platform may have some advantages compared to conventional laparoscopy.
- Open Access
- 13 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33750
Molecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma
Hyperammonemic encephalopathy is a potentially fatal condition associated with fibrolamellar hepatocellular carcinoma. The mechanism involved in hyperammonemia in patients with fibrolamellar carcinoma was unclear until a possible physiopathological pathway was recently proposed. An ornithine transcarboxylase dysfunction was suggested as a result of increased ornithine decarboxylase activity induced by c-Myc overexpression. This c-Myc overexpression resulted from Aurora kinase A overexpression derived from the activity of a chimeric kinase that is the final transcript of a deletion in chromosome 19, common to all fibrolamellar carcinomas. We performed the analysis of the expression of all enzymes involved and tested for the mutation in chromosome 19 in fresh frozen samples of fibrolamellar hepatocellular carcinoma, non-tumor liver, and hepatic adenomatosis. The specific DNAJB-PRKACA fusion protein that results from the recurrent mutation on chromosome 19 common to all fibrolamellar carcinoma was detected only in the fibrolamellar carcinoma sample. Fibrolamellar carcinoma and adenomyomatosis samples presented increased expression of Aurora kinase A, c-MYC, and ornithine decarboxylase when compared to normal liver, while ornithine transcarbamylase was decreased. The proposed physiopathological pathway is correct and that overexpression of c-Myc may also be responsible for hyperammonemia in patients with other types of rapidly growing hepatomas. This gives further evidence to apply new and adequate treatment to this severe complication.
- 13 January 2023
- Published by Springer Nature in Cureus
- Vol. 15 (1) , e33750
Open AccessMolecular Basis of Hyperammonemic Encephalopathy in Fibrolamellar Hepatocellular Carcinoma
Hyperammonemic encephalopathy is a potentially fatal condition associated with fibrolamellar hepatocellular carcinoma. The mechanism involved in hyperammonemia in patients with fibrolamellar carcinoma was unclear until a possible physiopathological pathway was recently proposed. An ornithine transcarboxylase dysfunction was suggested as a result of increased ornithine decarboxylase activity induced by c-Myc overexpression. This c-Myc overexpression resulted from Aurora kinase A overexpression derived from the activity of a chimeric kinase that is the final transcript of a deletion in chromosome 19, common to all fibrolamellar carcinomas. We performed the analysis of the expression of all enzymes involved and tested for the mutation in chromosome 19 in fresh frozen samples of fibrolamellar hepatocellular carcinoma, non-tumor liver, and hepatic adenomatosis. The specific DNAJB-PRKACA fusion protein that results from the recurrent mutation on chromosome 19 common to all fibrolamellar carcinoma was detected only in the fibrolamellar carcinoma sample. Fibrolamellar carcinoma and adenomyomatosis samples presented increased expression of Aurora kinase A, c-MYC, and ornithine decarboxylase when compared to normal liver, while ornithine transcarbamylase was decreased. The proposed physiopathological pathway is correct and that overexpression of c-Myc may also be responsible for hyperammonemia in patients with other types of rapidly growing hepatomas. This gives further evidence to apply new and adequate treatment to this severe complication.
- Open Access
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 59 (1) , 154-156
ROBOTIC APPROACH FOR THE TREATMENT OF GIANT COLONIC DIVERTICULUM
- 1 March 2022
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 59 (1) , 154-156
Open AccessROBOTIC APPROACH FOR THE TREATMENT OF GIANT COLONIC DIVERTICULUM
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (3) , 408-410
FIRST TOTALLY ROBOTIC MESOHEPATECTOMY WITH SELECTIVE HEPATIC ARTERY CLAMPING FOR THE TREATMENT OF A COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (3) , 408-410
Open AccessFIRST TOTALLY ROBOTIC MESOHEPATECTOMY WITH SELECTIVE HEPATIC ARTERY CLAMPING FOR THE TREATMENT OF A COMBINED HEPATOCELLULAR-CHOLANGIOCARCINOMA
- Open Access
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (3) , 413-414
DEFINITIVE PYLORIC CLOSURE FOR TREATMENT OF DIGESTIVE FISTULA AFTER PANCREATODUODENECTOMY WITH OVER-THE-SCOPE CLIP (PADLOCK)
- 1 September 2021
- Published by FapUNIFESP (SciELO) in Arquivos de Gastroenterologia
- Vol. 58 (3) , 413-414
Open AccessDEFINITIVE PYLORIC CLOSURE FOR TREATMENT OF DIGESTIVE FISTULA AFTER PANCREATODUODENECTOMY WITH OVER-THE-SCOPE CLIP (PADLOCK)